Spot Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Spot Trading’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$78K	Sell	26,900 -4,300	-14%	-$14.7K	﹤0.01%	2627
2017 Q2	$139K	Hold	31,200	–	–	﹤0.01%	2432
2017 Q1	$145K	Buy	+31,200	New	+$181K	﹤0.01%	2088
2016 Q3	–	Sell	-5,000	Closed	-$19K	–	3761
2016 Q2	$19K	Sell	5,000 -50,000	-91%	-$169K	﹤0.01%	2990
2016 Q1	$152K	Buy	+55,000	New	+$199K	﹤0.01%	2373
2015 Q2	–	Sell	-400	Closed	-$2K	–	4431
2015 Q1	$2K	Buy	+400	New	+$1.3K	﹤0.01%	3757

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Spot Trading's SGYP Position: Q3 2017 in Review

Spot Trading reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 4.1% in Q3 2017, selling an estimated $3.69K and leaving 25,199 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Spot Trading first reported a position in SGYP in Q2 2014 and has held it in 6 quarters since. The position peaked at $137K in Q2 2014. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

Spot Trading held 25,199 shares of Synergy Pharmaceuticals, Inc Common Stock worth $73K as of Q3 2017.
Spot Trading sold 1,082 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $3.69K.
Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2649 holding.
Spot Trading first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and has held it in 6 quarters since.
Spot Trading's Synergy Pharmaceuticals, Inc Common Stock position peaked at $137K in Q2 2014.
143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.